SCHEMBL121561

SCHEMBL121561

C1=CCCNC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28158190 0.97
SCHEMBL28229715 0.84
SCHEMBL1007363 0.82
SCHEMBL1007364 0.82
SCHEMBL1835260 0.80
SCHEMBL16915527 0.80
SCHEMBL16915528 0.80
SCHEMBL28759165 0.80
SCHEMBL16915509 0.78
SCHEMBL16915511 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1696 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 WO claimed
US-20230225190-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-13 US claimed
US-11613649-B2 Thermally-rearranged polymer blends for gas separation membranes BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-03-28 US claimed
EP-4126229-A1 MTORC1 MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2023-02-08 EP claimed
CN-113861128-A Polymerizable compound and optically anisotropic body 江苏创拓新材料有限公司 2021-12-31 CN claimed
WO-2021195599-A1 MTORC1 MODULATORS AND USES THEREOF AEOVIAN PHARMACEUTICALS, INC. (US) 2021-09-30 WO claimed
US-20210095122-A1 THERMALLY-REARRANGED POLYMER BLENDS FOR GAS SEPARATION MEMBRANES UNITED STATES DEPARTMENT OF ENERGY 2021-04-01 US claimed
US-9416143-B2 Griseofulvin derivatives PIERRE FABRE MEDICAMENT (FR) 2016-08-16 US claimed
US-20150210713-A1 GRISEOFULVIN DERIVATIVES PIERRE FABRE MEDICAMENT (FR) 2015-07-30 US claimed
EP-2880023-A1 GRISEOFULVIN DERIVATIVES PIERRE FABRE MEDICAMENT (FR) 2015-06-10 EP claimed
US-20070232586-A1 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof OHMOTO KAZUYUKI 2007-10-04 US claimed
EP-1739081-A1 HYDRAZINO-SUBSTITUTED HETEROCYCLIC NITRILE COMPOUNDS AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-03 EP claimed
EP-1127052-B1 SUBSTITUTED 2-PHENYLBENZIMIDAZOLES, THE PRODUCTION THEREOF AND THEIR USE ABBOTT GMBH & CO KG (DE) 2004-12-08 EP claimed
EP-1056705-B1 STABLE HYPERFORIN SALTS, METHOD FOR PRODUCING SAME AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE SCHWABE WILLMAR GMBH & CO (DE) 2003-10-29 EP claimed
US-6444662-B1 REACTION WITH AMINE BASE WILLMAR SCHWABE GMBH & CO. (DE) 2002-09-03 US claimed
EP-1127052-A1 SUBSTITUTED 2-PHENYLBENZIMIDAZOLES, THE PRODUCTION THEREOF AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
EP-1056705-A1 STABLE HYPERFORIN SALTS, METHOD FOR PRODUCING SAME AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE Dr. Willmar Schwabe GmbH & Co. (DE) 2000-12-06 EP claimed
WO-2000026192-A1 SUBSTITUTED 2-PHENYLBENZIMIDAZOLES, THE PRODUCTION THEREOF AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 2000-05-11 WO claimed
WO-1999041220-A1 STABLE HYPERFORIN SALTS, METHOD FOR PRODUCING SAME AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE DR. WILLMAR SCHWABE GMBH & CO. (DE) 1999-08-19 WO claimed
US-4076537-A Light-sensitive materials containing organo tellurium or selenium compounds and sensitizers FUJI PHOTO FILM CO., LTD. (JA) 1978-02-28 US claimed